Who invested in Virdante Pharmaceuticals?
Virdante Pharmaceuticals's investors include Venrock, Osage University Partners, Osage Venture Partners, Clarus Ventures and MedImmune Ventures, and 2 more on record.
United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$60Mraised across 2 rounds since 2009, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $30M sold, first sale Jan 2008
Reported by onbiovc.comSEC filing: $30M sold, first sale Jan 2008
From the SEC filings it signed: 1 on the team.
On the board, as filediAnders Patrick HoveEric Patrick AguiarGail Patrick WassermanL. Patrick GageMichael Patrick Steinmetz
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Virdante Pharmaceuticals's investors include Venrock, Osage University Partners, Osage Venture Partners, Clarus Ventures and MedImmune Ventures, and 2 more on record.
Virdante Pharmaceuticals has raised $60M across 2 rounds since 2009.
Virdante Pharmaceuticals's most recent round was a Venture of $30M in Oct 2011.
Its most recent round, $30M in Oct 2011, is also its largest on record.
Virdante Pharmaceuticals's first round on record, in Nov 2009, was backed by Venrock, Osage University Partners and Osage Venture Partners and 4 others.
Virdante Pharmaceuticals's latest named round is a Venture, in Oct 2011.
Virdante Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.